All News
|
Research Feature
It is the fourth leading cause of death in the United States, affecting nearly 16 million people, but for many Americans, chronic obstructive pulmonary disease, or COPD, still remains a mystery. That’s why in 2017, at the request of Congress, the NHLBI led a year-long, multi-team effort to figure out what it would take to relieve the burden of this...
|
NHLBI in the Press
Fifty years of advancement into an ever-greater understanding of lung illnesses have whet the interest of the NHLBI’s Division of Lung Diseases (DLD) in precision medicine.
|
NHLBI in the Press
Teens with a single ventricle heart defect significantly improved their capacity to sustain moderate exercise by taking an oral medication. The trial results, researchers say, represent a milestone in the care for those who have undergone the Fontan procedure, a palliative operation for this patient
|
NHLBI in the Press
Researchers have discovered a new biological pathway that promotes chronic inflammation and may help explain why sedentary people have an increased risk for heart disease and strokes.
|
NHLBI in the Press
Researchers from dozens of leading institutions around that nation have proposed new criteria for diagnosing chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the United States.
|
NHLBI in the Press
An innovative method of measuring the immune system’s white blood cells from a small blood sample could provide significantly more prognostic information about patients with sepsis.
|
NHLBI in the Press
mplementation, the adoption of research findings in clinicians’ everyday practice, can be the Achilles’s heel of health care advancements and improvement in patients’ outcomes.
|
NHLBI in the Press
Women who give birth to five or more children have a higher risk for heart disease, obesity, high blood pressure, and are less likely to be physically active, according to a recent study.
|
NHLBI in the Press
Lung regeneration and repair has been a long-standing interest of NHLBI, since the creation of the Division of Lung Diseases (DLD) 50 years ago
|
NHLBI in the Press
Researchers are reporting development of a new delivery tool for gene-editing that targets a broad range of lung diseases including cystic fibrosis, COPD, and asthma.
|
NHLBI in the Press
Researchers have identified a specific gene, called HDAC9, that appears to play a key role in the buildup of calcium in the blood vessel walls. In the future, targeting this gene might provide a way to prevent or treat cardiovascular events such heart attacks and strokes, they say.
|
NHLBI in the Press
Scientists have identified a previously unknown regulatory role for well-known byproduct of cell metabolism that could help shed light on cancer, atherosclerosis, sepsis, and a host of other diseases.
|
NHLBI in the Press
Chronic stress may play a key role in the development of high blood pressure in African-Americans, a new study suggests.
|
NHLBI in the Press
Researchers are reporting that Valium and other benzodiazepines—sedatives used to treat anxiety, sleeping disorders, and other conditions—appear to work by a previously unknown mechanism.
|
NHLBI in the Press
A study partly funded by NHLBI shows potential link between bad quality sleep and Alzheimer’s disease in Hispanics/Latinos.
|
NHLBI in the Press
In a study of over 25,000 people ages 17-93 years, researchers found that smoking just a few cigarettes a day is as harmful to the lungs as smoking a pack or more per day.
|
NHLBI in the Press
Atherosclerotic plaques, a fatty buildup that over time hardens and narrows the arteries, contain an abundance of immune cells, according to a study published in Nature Medicine.
|
NHLBI in the Press
Researchers at the NIH have developed a new and improved viral vector—a virus-based vehicle that delivers therapeutic genes—for use in gene therapy for sickle cell disease.
|
NHLBI in the Press
A study by NIH researchers found that a high-performing, low-field MRI system could improve lung and cardiac imaging.
|
NHLBI in the Press
A study, published in the New England Journal of Medicine, found that African-Americans with poorly controlled asthma responded differently to commonly used treatments.